IVY RX Review: Following the Care Path From Online Intake to Medication Delivery

A telehealth weight-loss service is not one transaction. A questionnaire leads to a clinical decision, a prescription may move to a pharmacy, and a shipment eventually reaches the patient. IVY RX advertises that journey with an online assessment, same-day physician review, free delivery and messaging through a patient portal. The practical question is how clearly the company documents responsibility at each handoff—not simply how quickly someone can begin an application or how low the advertised starting price appears.

This review examines IVY RX’s public documentation consulted October 19, 2026. The company markets compounded semaglutide and tirzepatide, including a microdose offering, alongside other treatments and supplements. Its pages provide useful details about intake, packaging and subscription management, but do not establish the named dispensing pharmacies, state-by-state availability or a defined clinical follow-up schedule. For adults considering the service, the strongest preparation is to separate what IVY RX promises, what its terms require and what still needs an answer before payment.

At a glance

Clinical pathway: IVY RX says it arranges an online consultation for prescription items; if approved, a partner pharmacy can fill the prescription.
Sources: [5]
Advertised medication prices: GLP-1 medication starts at $77 and microdose GLP-1 starts at $69, each displayed with “4 doses/month.” The documentation does not establish a complete price for every formulation or plan.
Sources: [5] [3]
Delivery expectations: Product advertising says medication can arrive in as little as two days; the help center says delivery occurs within three to five business days in most cases.
Sources: [5] [9]
Recurring payments: The terms describe self-pay subscriptions, one-month or three-month prepaid options, and monthly automatic renewal.
Sources: [7]
Refund boundaries: Physical returns are not accepted. Separately, the terms allow a refund request within 15 days of an order, without promising approval.
Sources: [10] [7]

Start with who is responsible for the care

IVY RX describes itself as arranging consultations with qualified healthcare providers for prescription products. Approval is conditional, and a partner pharmacy can then fill the prescription. The company says its affiliated doctors are board-certified, U.S.-licensed healthcare professionals; those credentials were not independently verified for this review. The distinction matters because the website, evaluating clinician and dispensing pharmacy perform different functions. A prospective patient should know which organization handles each one before assuming a single support channel covers every problem.

The terms name Ivy Rx, PLLC as the agreement’s counterparty, while the consulted documentation also displays Ivy Health Inc. in a footer. Their relationship is not clarified. Published contact information includes 866-464-8979, hello@ivyrx.com and 111 NE 1st Street, 8th Floor #8564, Miami, FL 33132. That address does not establish an in-person clinic. The documentation also does not establish which states or territories the service covers, so a mailing address should not be mistaken for nationwide prescribing availability.

For practical preparation, ask for the treating clinician’s name, the entity providing medical care and confirmation that service is available at your location. The public material does not confirm video visits, Spanish-language care or interpretation services. Those details can determine whether an online process fits a person’s communication needs. Our guide to clinicians and telehealth platforms explains why identifying these separate responsibilities is useful before enrolling.

The documented handoffs—and the questions left open
Stage	What IVY RX documents	What to clarify
Intake	Online questions about symptoms and health history	Whether a live visit is available or required
Clinical review	Advertised same-day physician review; approval emailed	Who reviews the case and what happens if more information is needed
Pharmacy	A partner pharmacy can fill an approved prescription	Pharmacy identity and exact dispensed formulation
Delivery	Free shipping; temperature-controlled packaging advertised for GLP-1	Tracking, temperature concerns and replacement procedures
Ongoing care	Portal messaging, live support and a free mobile app	Clinical response times, follow-up schedule and refill requirements

Sources: [7] [6] [5]

The assessment is online; eligibility is less clearly defined

The advertised intake asks questions about symptoms and health history entirely online. IVY RX promotes a five-minute assessment, same-day physician review and approval communicated by email. These are separate steps: completing the questionnaire is not approval, and approval is not shipment. The product pages also say laboratory work is not needed. That describes the advertised access process; it does not establish what an individual clinician might need to resolve a particular medical question.

The website’s BMI labels deserve clarification rather than self-interpretation. Its calculator calls people below 22 ineligible, labels microdose GLP-1 as below 24.99, and labels full-dose GLP-1 as above 25. These statements leave overlap and boundary values unresolved. The site’s adult-use terms require users to be at least 18, or otherwise the age of majority in their jurisdiction, but that is a platform-access rule—not a finding of clinical suitability.

The provider also publishes exclusions involving medullary thyroid carcinoma history, MEN2, pregnancy, trying to become pregnant and breastfeeding. Those statements should be discussed with the evaluating clinician, not treated as a complete screening checklist. NIDDK describes medication selection as a discussion of health conditions, other medicines, family history, benefits, side effects and costs. Its general adult BMI thresholds differ from IVY RX’s calculator labels; neither set of numbers by itself determines an individual’s treatment.

Sources: [5] [3] [7] [2]

Identify the product before comparing the program

IVY RX explicitly markets compounded semaglutide and tirzepatide. Its microdose page likewise describes compounded preparations containing either ingredient. The broader catalog links to GLP-1 injections, microdose products, oral melts, Ozempic, Mounjaro, metformin, MIC + B12 injections and anti-nausea tablets. A menu entry, however, does not confirm present availability, an individual prescription or the conditions attached to that product. Ingredient names alone are not enough to identify the medicine someone would actually receive.

Before authorizing a charge, request the exact product, formulation, route, concentration and presentation, along with the pharmacy that would dispense it. The consulted pages do not map every advertised starting price to those details. This is especially important when moving between an injection listing, an oral-melt listing and a microdose description. The product and formulation checklist offers a framework for distinguishing these features without treating similarly named products as interchangeable.

The supplement called GLP-1 Boost is a separate offering, advertised from $72 for 30 tablets. Its FAQ says it contains neither GLP-1 nor synthetic peptides. Its own safety text acknowledges limited human clinical data for the exact combination and says it is not a substitute for prescribed medication. The listing also contains inconsistent references to tablets, a vegetable capsule and an injection-related pH test. Those inconsistencies warrant clarification rather than assuming the supplement belongs to the prescription pathway.

Sources: [5] [3] [4] [8]

The pharmacy handoff needs a name, not just standards

IVY RX says its treatments are compounded in pharmacies compliant with 503B/USP <797> standards. It also describes preparation in a state-licensed pharmacy and independent verification in FDA- and DEA-registered laboratories. These are provider statements, not independently verified accreditations in this review. The consulted material does not name the dispensing pharmacies or laboratories, preventing a reader from connecting the general claims to the organization that would handle a specific prescription.

The product page describes potency testing every three to six months, targeting a concentration within ±10% of the intended strength, and sterility screening for bacteria, fungi and other contaminants under USP 797 standards. These details are more informative than an unspecified quality promise, but they do not establish which results apply to a particular shipment. Ask who can answer product-specific questions and provide the relevant documentation, rather than assuming periodic testing describes every dispensed container.

FDA states that compounded preparations are not FDA approved and do not undergo its premarket review for safety, effectiveness and quality. Nonapproval alone does not prove clinical inequivalence. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Neither laboratory registration nor a website’s quality language makes a compounded preparation FDA approved. Approval attaches to a specific product, not to a clinic’s overall service.

Sources: [5] [1]

Delivery has several clocks—and a temperature question

For GLP-1 orders, IVY RX advertises free delivery in discreet, temperature-controlled packaging. Its product page says medication may arrive in as little as two days, while the help center describes three to five business days in most cases. Those claims are not interchangeable guarantees. Same-day review concerns the clinical decision; delivery concerns the package’s arrival. The documentation does not provide a complete timeline showing when pharmacy processing begins or how an incomplete assessment affects the estimate.

The consulted pages do not identify carriers, tracking arrangements, replacement rules for lost or damaged shipments, or a specific process for temperature incidents. Before ordering, ask which contact handles delivery trouble and whether the pharmacy can assess a questionable package. Our explanation of approval, dispatch and arrival helps keep these milestones separate. A fast advertised minimum should not substitute for a plan when the package does not arrive as expected.

FDA explicitly advises not using an injectable GLP-1 drug that arrives warm or with insufficient refrigeration, and contacting the provider or dispensing pharmacy. That instruction matters even when temperature-controlled packaging was advertised. The review cannot determine a shipment’s condition from packaging claims, and the public documentation does not settle how IVY RX would investigate or replace an affected order. Obtain a contact route for that situation before the first shipment rather than after a problem appears.

Sources: [5] [9] [1]

Portal access is documented; a follow-up schedule is not

Patients can securely message care providers through the patient portal, according to IVY RX. The product page also advertises live support and a free mobile app. The refund-policy page lists support@ivyrx.com and says support is available seven days a week, without specifying hours or response times. These are useful access routes, but administrative availability should not be read as a promise that a prescribing clinician will respond immediately or on a particular schedule.

The documentation does not establish routine follow-up frequency, prescription-renewal requirements or guaranteed clinical response times. Ask whether check-ins are scheduled or patient-initiated, who reviews reports of tolerability problems and what must happen before another prescription is authorized. A renewed payment and a renewed clinical assessment are different events. The guide to ongoing GLP-1 support explains how to turn broad access promises into concrete questions about continuity of care.

NIDDK emphasizes that follow-up concerns response and tolerance, not merely continued access to medication. FDA has also received reports of measurement or administration errors involving compounded drugs, including some associated with hospitalization. That context makes access to clear, product-specific instructions important. Patients should clarify instructions with the prescriber or pharmacist rather than calculate a dose from a review. Nothing in IVY RX’s public support descriptions establishes how frequently those conversations occur.

Sources: [5] [10] [2] [1]

Understand the charge before the prescription moves forward

The GLP-1 listing advertises “From $77” with “4 doses/month”; microdose GLP-1 advertises “From $69” with the same four-dose wording. These are starting-price statements, not documented universal prices for both molecules or every presentation. The pages do not establish the full final charge, which prepaid option applies, included injection supplies or possible additional fees. The four-dose wording should not be expanded into assumptions about shipment quantity beyond what the provider actually confirms.

The homepage advertises a free consultation, free delivery and no insurance requirement. The terms describe a self-pay arrangement and subscriptions consisting of either one month prepaid or three months prepaid, followed by monthly automatic renewal. They do not connect each plan to the advertised product prices. Before paying, request a written breakdown of the amount collected now, the next charge date, the renewal amount and exactly which clinical, pharmacy and supply services that payment covers.

The product page says “Same price, every dose,” but the terms reserve the right to increase subscription fees. That prevents reading the marketing as a permanent price lock. IVY RX also says GLP-1 therapy is HSA/FSA-eligible and that it provides an itemized receipt for reimbursement submission. That is a provider claim and a documentation service, not confirmation that a particular account will reimburse the purchase. No insurance requirement likewise does not establish insurance coverage.

Sources: [5] [3] [6] [7]

Stopping renewal and recovering money are different processes

IVY RX’s weight-loss page advertises no long-term contracts and no cancellation fees. Its terms nevertheless describe prepaid subscription options and automatic monthly renewal. To avoid the next monthly charge, the terms say cancellation must occur before the current subscription period ends. The billing clause allows cancellation or modification through the patient portal, while another section directs users to support. Confirm the effective date and keep a record; cancellation does not itself establish a refund entitlement.

The separate refund policy says physical returns are not accepted and encourages customers to contact the company to seek a solution. The terms provide a more specific request process: contact info@ivyrx.com within 15 days of the order using the subject “Refund Request.” After that period, the terms say sales are final and ineligible for refund. Permission to request a refund is not a promise that one will be granted.

The documentation does not clarify how that request window applies to prescribed medication or products already shipped. Nor does a statement about no cancellation fees resolve what happens to an unused portion of a prepaid period. Before enrolling, ask how denial of a prescription, cancellation before dispensing and a shipment problem are handled financially. These are distinct situations, and a general assurance that support will help does not establish their outcomes.

Sources: [7] [4] [10]

Questions & answers

Does completing IVY RX’s assessment guarantee a prescription?

No. IVY RX says it arranges a consultation for prescription products and that a partner pharmacy can fill the prescription if approved. Its same-day review and emailed-approval advertising does not guarantee approval. Ask what happens if the clinician needs additional information or declines treatment, including whether any collected payment is refundable.

Sources: [5] [7]

Is $77 the complete monthly price for compounded tirzepatide?

The consulted documentation does not establish that. The GLP-1 page advertises a starting price of $77 with four doses per month, but does not identify it as a universal tirzepatide price. Request the exact formulation, presentation, upfront collection, renewal charge and included services. The terms’ one-month and three-month prepaid options are not mapped to that starting figure.

Sources: [5] [7]

Which pharmacy would dispense my IVY RX prescription?

The consulted pages do not name the pharmacy that would handle a particular order. IVY RX describes partner pharmacies and makes claims about state licensing, compounding standards and laboratory verification. Ask for the dispensing pharmacy’s identity and contact information before shipment, including whom to contact about instructions, the product label or a temperature concern.

Sources: [5]

Should I plan on receiving medication within two days?

Not as a guaranteed deadline. “As little as 2 days” is the product page’s promotional minimum, while the help center says most deliveries take three to five business days. Clinical review, pharmacy processing and arrival are different milestones. Confirm the order-specific estimate and what happens if delivery is delayed before arranging around the advertised minimum.

Sources: [5] [9]

Can I contact a clinician after medication arrives?

IVY RX says patients can message care providers through its portal. It also advertises live support, a free app and support availability seven days a week. The public documentation does not specify clinician response times or a routine follow-up schedule. Confirm which channel reaches clinical staff and how refill reviews and medication questions are handled.

Sources: [5] [10]

If I cancel, will IVY RX return my payment?

Cancellation and refund requests are separate. The terms require cancellation before the current period ends to prevent the next renewal, and allow plan management through the portal. Refund requests must be emailed within 15 days of the order to info@ivyrx.com with “Refund Request” as the subject. Approval is not promised, and physical returns are not accepted.

Sources: [7] [10]

Our assessment

IVY RX documents a recognizable telehealth pathway: online intake, conditional clinical approval, partner-pharmacy dispensing, free delivery and portal-based communication. Its packaging descriptions, stated delivery range and specific cancellation routes provide useful starting points. The weaker part is the connection between those promises and an individual order: the named clinician and pharmacy, exact formulation, complete charge, follow-up schedule and handling of shipping or refund disputes remain insufficiently defined. Before enrolling, obtain those answers in writing and reconcile the checkout terms with the advertised starting price. The service is documented as a GLP-1 provider, but its public pages alone do not establish independently verified pharmacy quality, individual suitability or a fully specified ongoing care arrangement.

Visit IVY RX’s official site ↗

This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.

FOLLOW THE EVIDENCE

Research behind treatment claims

Use these studies to assess the type of outcome a treatment claim describes. They did not test this provider or establish results for its products.

SURMOUNT-5: What a Direct Weight-Loss Comparison Can—and Cannot—Tell You About Ongoing Care
Tirzepatide produced greater average weight and waist reductions than semaglutide over 72 weeks. Understanding the trial’s design matters just as much as understanding the difference.
After the Weight Loss: What SURMOUNT-4 Means for Continuity of Care
Randomized tirzepatide withdrawal separates maintaining a treatment effect from finishing a course. Reading its two baselines—and newer maintenance-dose research—shows what the evidence can and cannot tell patients changing care.

Explore the science library →

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

IVY RX Review: Following the Care Path From Online Intake to Medication Delivery

At a glance

01Start with who is responsible for the care

02The assessment is online; eligibility is less clearly defined

03Identify the product before comparing the program

04The pharmacy handoff needs a name, not just standards

05Delivery has several clocks—and a temperature question

06Portal access is documented; a follow-up schedule is not

07Understand the charge before the prescription moves forward

08Stopping renewal and recovering money are different processes